First vaccine for chikungunya virus, an ‘rising world well being risk,’ will get FDA approval
The U.S. Meals and Drug Management (FDA) on Thursday introduced its approval of Ixchiq, the primary chikungunya vaccine.The vaccine, which is made by means of Valneva, is authorized for someone age 18